Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells

Glycobiology

Volumn 24, Issue 4, 2014, Pages 359-367

  Lu, Chun Hao ^a   Wu, Wan Yi ^a   Lai, Yin Ju ^a,b   Yang, Chen Ming ^a   Yu, Lung Chih ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

B3GNT7; colon cancer; DNA methylation; metastasis

Indexed keywords

MEMBRANE ANTIGEN; SIALYL LEWIS A ANTIGEN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG; B3GNT1 PROTEIN, HUMAN; B3GNT7 PROTEIN, HUMAN; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA 1,3 N ACETYLGLUCOSAMINYLTRANSFERASE GENE; CANCER CELL CULTURE; CELL MIGRATION; CELL SURFACE; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; MALE; METASTASIS; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; ADENOCARCINOMA; ANIMAL; BIOSYNTHESIS; CELL MOTION; COLON TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM METASTASIS; RNA, MESSENGER;

EID: 84898958527     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu002     Document Type: Article

References (41)

1. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. 1998. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 58:5489-5494. (Pubitemid 28551135)
2. Boyden S. 1962. The chemotactic effect of mixtures of antibody and antigen on polymophonuclear leucocytes. J Exp Med. 115:453-466.
3. Esteller M. 2005. Aberrant DNA methylation as a cancer-inducing mechanism. Annu Rev Pharmacol Toxicol. 45:629-656. (Pubitemid 40261820)
4. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA. 89:1827-1831.
5. Fukuda M. 1996. Possible role of tumor-Associated carbohydrate antigens. Cancer Res. 56:2237-2244. (Pubitemid 26154066)
6. Fukuda M. 2001. Cell surface carbohydrates: Cell type-specific expression. In: Fukuda M, Hindsgaul O, editors. Molecular and Cellular Glycobiology. New York, NY: Oxford University Press. p. 1-61.
7. Gardiner-Garden M, Frommer M. 1987. CpG islands in vertebrate genomics. J Mol Biol. 196:261-282.
8. Gillies RJ, Didier N, Denton M. 1986. Determination of cell number in monolayer cultures. Anal Biochem. 159:109-113. (Pubitemid 17228232)
9. Hakomori S. 1989. Aberrant glycosylation in tumors and tumor-Associated carbohydrate antigens. Adv Cancer Res. 52:257-231.
10. Hakomori S. 1996. Tumor malignancy defined by aberrant glycosylation and sphinogo(glyco)lipid metabolism. Cancer Res. 56:5309-5318. (Pubitemid 27011703)
11. Hakomori S. 2002. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA. 99:10231-10233.
12. Ishida H, Togayachi A, Sakai T, Iwai T, Hiruma T, Sato T, Okubo R, Inaba N, Kudo T, Gotoh M, et al. 2005. A novel β1,3-N- Acetylglucosaminyltransferase (β3Gn-T8), which synthesizes poly-N-Acetyllactosamine, is drastically upregulated in colon cancer. FEBS Lett. 579:71-78. (Pubitemid 40023376)
13. Izawa M, Kumamoto K, Mitsuoka C, Kanamori A, Ohmori K, Ishida H, Nakamura S, Kurata-Miura K, Sasali K, Nishi T, et al. 2000. Expression of sialyl 6-sulfo Lewis x is inversely correlated with conventional sialyl Lewis x expression in human colorectal cancer. Cancer Res. 60:1410-1416. (Pubitemid 30152015)
14. Kannagi R. 1997. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J. 14:577-584. (Pubitemid 27353201)
15. Kannagi R. 2004. Molecular mechanism for cancer-Associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J. 20:353-364. (Pubitemid 39024043)
16. Kannagi R, Sakuma K, Miyazaki K, Lim KT, Yusa A, Yin J, Izawa M. 2010. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers. Cancer Sci. 101:586-593.
17. Kannagi R, Yin J, Miyazaki K, Izawa M. 2008. Current relevance of incomplete synthesis and neo-synthesis for cancer-Associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochim Biophys Acta. 1780:525-531. (Pubitemid 351381253)
18. Kataoka K, Huh N. 2002. A novel β1,3-N-Acetylglucosaminyltransferase involved in invasion of cancer cells as assayed in vitro. Biochem Biophys Res Commun. 294:843-848. (Pubitemid 34687193)
19. Kataoka K, Nakajima A, Takata Y, Saito S, Huh N. 2001. Screening for genes involved in tissue invasion based on placenta formation and cancer cell lines with low and high metastatic potential. Cancer Lett. 163:213-219. (Pubitemid 32126368)
20. Kawamura YI, Kawashima R, Fukunaga R, Hirai K, Toyama-Sorimachi N, Tokuhara M, Shimizu T, Dohi T. 2005. Introduction of Sda carbohydrate antigen in gastrointestinal cancer cells eliminates selectin ligands and inhibits metastasis. Cancer Res. 65:6220-6227. (Pubitemid 40994407)
21. Kitayama K, Hayashida Y, Nishida K, Akama TO. 2007. Enzymes responsible for synthesis of corneal keratan sulfate glycosaminoglycans. J Biol Chem. 282:30085-30096. (Pubitemid 350035267)
22. Klose RJ, Bird AP. 2006. Genomic DNA methylation: The mark and its mediators. Trends Biochem Sci. 31:89-97. (Pubitemid 43221841)
23. Koike T, Kimura N, Miyazaki K, Yabuta T, Kumamoto K, Takenoshita S, Chen J, Kobayashi M, Hosokawa M, Taniguchi A, et al. 2004. Hypoxia induces adhension molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci USA. 101:8132-8137. (Pubitemid 38698066)
24. Kondo Y, Issa JP. 2004. Epigenetic changes in colorectal cancer. Cancer Metast Rev. 23:29-34.
25. Lao VV, Grady WM. 2011. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 8:686-697.
26. Miyazaki K, Ohmori K, Izawa M, Koike T, Kumamoto K, Furukawa K, Ando T, Kiso M, Yamaji T, Hashimoto Y, et al. 2004. Loss of diaialyl Lewisa, the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobinlike lectin-7 (Siglec-7) associated with increased sialyl-Lewisa expression on human colon cancers. Cancer Res. 64:4498-4505. (Pubitemid 38856921)
27. Nakagoe T, Fukushima K, Hirota M, Kusano H, Ayabe H, Tomita M, Kamihiri S. 1993. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. Cancer. 72:2320-2330.
28. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T. 1993. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res. 53:3632-3637. (Pubitemid 23229648)
29. Nakayama T, Watanabe M, Katsumata T, Teramoto T, Kitajima M. 1995. Expression of sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer. 75:2051-2056.
30. Narimatsu H. 2006. Human glycogene cloning: Focus on β3- glycosyltransferase and β4-glycosyltransferase families. Curr Opin Struct Biol. 16:567-575. (Pubitemid 44466414)
31. Ono M, Hakomori S. 2004. Glycosylation defining cancer cell motility and invasiveness. Glycoconj J. 20:71-78. (Pubitemid 38392180)
32. Quantock AJ, Young RD, Akama TO. 2010. Structural and biochemical aspects of keratan sulfate in the cornea. Cell Mol Life Sci. 67:891-906.
33. Scarano MI, Strazzullo M, Matarazzo MR, D'Esposito M. 2005. DNA methylation 40 years later: Its role in human health and disease. J Cell Physiol. 204:21-35. (Pubitemid 40776803)
34. Seko A, Dohmae N, Takio K, Yamashita K. 2003. β1,4-N- Galactosyltransferase (β4GalT)-IV is specific for GlcNAc 6-O-sulfate. J Biol Chem. 278:9150-9158.
35. Seko A, Yamashita K. 2004. β1,3-N-Acetylglucosaminyltransferase-7 (β3Gn-T7) acts efficiently on keratan sulfate-related glycans. FEBS Lett. 556:216-220. (Pubitemid 38058582)
36. Shimono R, Mori M, Akazawa K, Adachi Y, Sgimachi K. 1994. Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma. Am J Gastroenterol. 89:101-105. (Pubitemid 24020061)
37. Stanley P, Schachter H, Taniguchi N. 2009. N-Glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. 2nd ed. New York, NY: Cold Spring Harbor Laboratory Press. p. 101-114.
38. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB. 2002. A genetic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 31:141-149.
39. Toyota M, Ahuja N, Ohe-Toyoto M, Herman JG, Baylin SB, Issa JP. 1999. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA. 96:8681-8686. (Pubitemid 29354851)
40. Yin J, Miyazaki K, Shaner RL, Merrill AH, Kannagi R. 2010. Altered sphinogolipid metabolism induced by tumor hypoxia-New vistas in glycolipid tumor markers. FEBS Lett. 584:1872-1878.
41. Yusa A, Miyazaki K, Kimura N, IzawaM, Kannagi R. 2010. Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells. Cancer Res. 70:4064-4073.